Veeva Launches Falcon Router for AI Safety Reporting
Pleasanton, California, U.S., September 21, 2026 Veeva Systems has introduced Veeva Falcon Router, an agentic artificial intelligence solution designed...
AI drug discovery artificial intelligence Autoimmune Disease biologics biopharma Biopharmaceuticals Biotechnology Bispecific Antibody Cancer Immunotherapy Cancer Research cancer therapy Cancer Treatment Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development Drug Discovery EMA FDA fda approval FDA clearance Gene Therapy healthcare technology Immuno-Oncology immunology Immunotherapy Medical Devices MedTech Monoclonal Antibody Neurology Oncology Ophthalmology Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 Phase 3 trial Precision Medicine Precision Oncology rare disease Regenerative Medicine targeted therapy
Pleasanton, California, U.S., September 21, 2026 Veeva Systems has introduced Veeva Falcon Router, an agentic artificial intelligence solution designed...
Germantown, Maryland, U.S., September 21, 2026 Precigen has announced that the U.S. Food and Drug Administration (FDA) has granted...
RANCHO CORDOVA, Calif., June 23, 2026 SK pharmteco has introduced SKyvecâ„¢, a next-generation multimodal viral vector platform designed to...
COLLEGE STATION, Texas, June 9, 2026 Matica Biotechnology announced an agreement with University Health Network (UHN) to provide cGMP...
